Hosted on MSN

Addyi: FDA approves libido-boosting drug for postmenopausal women – what does it mean for women’s sexual health?

U.S. health authorities have widened the approval of a closely debated medication designed to increase female libido, allowing the once-daily pill to be used by women over the age of 65. The decision, ...
AOL

She Created The First Female Libido Pill—And Advocates For Women’s Pleasure. Are Experts Finally Listening?

Cindy Eckert first learned about hypoactive sexual desire disorder (HSDD)—the most common type of sexual dysfunction in women—while attending a conference as a cofounder of Slate Pharmaceuticals, a ...
Hosted on MSN

What ob-gyns think about the first libido-boosting pill approved for use after menopause

Up until now, women who’d surpassed menopause and were dealing with frustratingly low libido—a.k.a. hypoactive sexual desire disorder (HSDD)—had no dedicated treatment option available to them. But ...
MarketWatch

Sprout Pharmaceuticals' Addyi(R) (flibanserin) Named "Best Prescription for Low Libido" in the 2026 Oprah Daily Menopause O-wards

The MarketWatch News Department was not involved in the creation of this content. Recognition follows Addyi's newly expanded FDA approval to treat both premenopausal and postmenopausal women under age ...
Time

Female Sexual Dysfunction: Myth or Malady?

Follow this author to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this author to personalize your feed and get ...
Medical News Today

FDA approves daily pill to treat low libido in women after menopause: What to know

Share on Pinterest The FDA has expanded its approval of a libido-boosting drug to postmenopausal women. Xvision/Getty Images On December 15, 2025, the U.S. FDA approved Addyi (flibanserin) for the ...